Dunkin' Brands
Dunkin' Brands Group, Inc. was an American restaurant holding company which ran two chains of fast-food restaurants: Dunkin' Donuts and Baskin-Robbins. The company was headquartered in Canton, Massachusetts.
History
Dunkin' Brands was originally founded as Allied Domecq Quick Service Restaurants, a subsidiary of Allied Domecq. In 2004, the company was acquired by a consortium of private equity firms including Bain Capital, Carlyle Group, and Thomas H. Lee Partners. The company was renamed Dunkin' Brands in 2006.
In 2011, Dunkin' Brands became a publicly traded company on the NASDAQ under the ticker symbol DNKN. In December 2020, Dunkin' Brands was acquired by Inspire Brands, a multi-brand restaurant company.
Operations
Dunkin' Brands operated two primary brands:
- Dunkin' Donuts: A global doughnut and coffeehouse chain founded in 1950 by William Rosenberg in Quincy, Massachusetts. The chain is known for its wide variety of doughnuts, bagels, and coffee beverages.
- Baskin-Robbins: An international chain of ice cream and cake specialty shops founded in 1945 by Burt Baskin and Irv Robbins in Glendale, California. The chain is famous for its "31 flavors" slogan, with the idea that a customer could have a different flavor every day of the month.
Corporate Structure
Dunkin' Brands was structured to support its franchisees, providing marketing, operational, and training support. The company generated revenue through franchise fees, royalties, and sales of products to franchisees.
Acquisition by Inspire Brands
In October 2020, it was announced that Dunkin' Brands would be acquired by Inspire Brands for $11.3 billion. The acquisition was completed in December 2020, making Dunkin' Brands a subsidiary of Inspire Brands, which also owns other restaurant chains such as Arby's, Buffalo Wild Wings, and Sonic Drive-In.
See Also
- Dunkin' Donuts
- Baskin-Robbins
- Inspire Brands
- Allied Domecq
- Bain Capital
- Carlyle Group
- Thomas H. Lee Partners
References
External Links
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa
Tired of being overweight?
Get started with evidence based, physician-supervised
affordable GLP-1 weight loss injections
Now available in New York City and Philadelphia:
- Semaglutide starting from $59.99/week and up
- Tirzepatide starting from $69.99/week and up (dose dependent)
✔ Evidence-based medical weight loss ✔ Insurance-friendly visits available ✔ Same-week appointments, evenings & weekends
Learn more:
Start your transformation today with W8MD weight loss centers.
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
